C7orf33

Across TCGA pan-cancer cohorts, C7orf33 Mutation is linked to patient survival in 2 of 34 cancer types, making it a survival-associated C7orf33 data layer compared with 19 for mass-spec protein.

The strongest signal is observed in thyroid carcinoma (THCA), where higher C7orf33 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated C7orf33 expression acts as an unfavorable survival marker.

THCA and LUAD are the cancer types where C7orf33 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
THCA	OS	Median	All	0.294	0.945	<.001	8	view →
LUAD	OS	Median	III,IV	0.068	0.680	<.001	6	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

C7orf33–THCA (OS)

Open the THCA breakdown →